Cargando…

REBACIN(®) inhibits E6/E7 oncogenes in clearance of human papillomavirus infection

Previous studies have demonstrated that REBACIN(®) intervention eliminates persistent high-risk human papillomavirus (hrHPV) infection. The initial establishment and subsequent progression of cervical cancer mainly depends on two major oncogenes, E6/E7, and previous studies have proposed E6/E7 oncog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Shu-Guang, Wu, Dai-Fei, Yao, Hui, Zhang, Wei-Yu, Tian, Feng-Jiao, Chen, Guo, Zhang, Chun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763439/ https://www.ncbi.nlm.nih.gov/pubmed/36561517 http://dx.doi.org/10.3389/fonc.2022.1047222

Ejemplares similares

Case Report: Noninvasive Clinical Intervention of REBACIN® on Histologic Regression of High Grade Cervical Intraepithelial Neoplasia
por: Wang, Fan, et al.
Publicado: (2021)

High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
por: Zheng, Yunji, et al.
Publicado: (2022)

Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker
por: Fontecha, Nerea, et al.
Publicado: (2016)

RNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection
por: Fontecha, Nerea, et al.
Publicado: (2017)

Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection
por: Dai, Wenkui, et al.
Publicado: (2021)

The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target
por: Kuroda, M, et al.
Publicado: (2005)

Evidence for direct interaction between the oncogenic proteins E6 and E7 of high-risk human papillomavirus (HPV)
por: Lim, JiaWen, et al.
Publicado: (2023)

Oncogenic comparison of human papillomavirus type 58 E7 variants
por: Law, Priscilla TY, et al.
Publicado: (2018)

Genetic variability in E6 and E7 oncogenes of human papillomavirus Type 16 from Congolese cervical cancer isolates
por: Boumba, Luc Magloire Anicet, et al.
Publicado: (2015)

Characterization of Intra-Type Variants of Oncogenic Human Papillomaviruses by Next-Generation Deep Sequencing of the E6/E7 Region
por: Lavezzo, Enrico, et al.
Publicado: (2016)

Human papillomavirus E6 and E7: What remains?
por: Vats, Arushi, et al.
Publicado: (2021)

Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes
por: OH, JI-EUN, et al.
Publicado: (2013)

Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer
por: Jayamohan, Sridharan, et al.
Publicado: (2019)

Corrigendum: Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer
por: Jayamohan, Sridharan, et al.
Publicado: (2021)

O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes
por: Kim, Minjun, et al.
Publicado: (2016)

Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58
por: Xu, Wan-Xiang, et al.
Publicado: (2016)

The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China
por: Zhang, Shao-Kai, et al.
Publicado: (2020)

Human Papillomavirus E6/E7 Expression in Preeclampsia-Affected Placentae
por: Reily-Bell, Ashley L., et al.
Publicado: (2020)

Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential
por: Zehbe, Ingeborg, et al.
Publicado: (2011)

Genetic variability in the E6 and E7 oncogenes of HPV52 and its prevalence in the Taizhou area, China
por: Yang, Zhi, et al.
Publicado: (2022)

hnRNP E1 Regulates HPV16 Oncogene Expression and Inhibits Cervical Cancerization
por: Song, Li, et al.
Publicado: (2022)

Genetic diversity of E6, E7 and the long control region in human papillomavirus type 16 variants in Beijing, China
por: Wang, Jiao, et al.
Publicado: (2022)

Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer
por: Zhang, Jin-Jun, et al.
Publicado: (2018)

Transforming Properties of Beta-3 Human Papillomavirus E6 and E7 Proteins
por: Minoni, Lucia, et al.
Publicado: (2020)

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
por: Pal, Asmita, et al.
Publicado: (2020)

HPV 16 E6/E7 Promote the Glucose Uptake of GLUT1 in Lung Cancer Through Downregulation of TXNIP Due to Inhibition of PTEN Phosphorylation
por: Tang, Jia-Yi, et al.
Publicado: (2020)

Interfering Human Papillomavirus E6/E7 Oncogenes in Cervical Cancer Cells Inhibits the Angiogenesis of Vascular Endothelial Cells via Increasing miR-377 in Cervical Cancer Cell-Derived Microvesicles
por: Zhang, Ying, et al.
Publicado: (2020)

E6 and E7 gene polymorphisms in human papillomavirus Type-6 identified in Southwest China
por: Chen, Zuyi, et al.
Publicado: (2019)

Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer
por: Sen, Prakriti, et al.
Publicado: (2018)

Genetic variation of E6 and E7 genes of human papillomavirus type 16 from central China
por: Li, Ting, et al.
Publicado: (2023)

Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis
por: Aggarwal, Charu, et al.
Publicado: (2020)

Genome Plasticity in Papillomaviruses and De Novo Emergence of E5 Oncogenes
por: Willemsen, Anouk, et al.
Publicado: (2019)

Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression
por: Liu, Shuling, et al.
Publicado: (2018)

In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line
por: Zhen, Shuai, et al.
Publicado: (2016)

Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins
por: Muñoz Bello, Jesus Omar, et al.
Publicado: (2015)

Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription
por: James, Claire D., et al.
Publicado: (2020)

Polymorphism of E6 and E7 Genes in Human Papillomavirus Types 31 and 33 in Northeast China
por: Yu, Miao, et al.
Publicado: (2023)

Genetic Variability in the E6/E7 Region of Human Papillomavirus 16 in Women from Ecuador
por: Zhingre, Alicia, et al.
Publicado: (2023)

Diagnosis of 25 genotypes of human papillomaviruses for their physical statuses in cervical precancerous/cancerous lesions: a comparison of E2/E6E7 ratio-based vs. multiple E1-L1/E6E7 ratio-based detection techniques
por: Zhang, Rong, et al.
Publicado: (2014)

Codon Optimization of the Human Papillomavirus E7 Oncogene Induces a CD8(+) T Cell Response to a Cryptic Epitope Not Harbored by Wild-Type E7
por: Lorenz, Felix K. M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uf9iv4epao0114tk08a0gcc5ut